Previous 10 | Next 10 |
home / stock / tlppf / tlppf news
2024-02-25 12:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Phase 3 data for As...
2024-02-22 23:36:10 ET Telix Pharmaceuticals Limited (TLPPF) Q4 2023 Earnings Conference Call February 22, 2024 17:00 ET Company Participants Kyahn Williamson - Senior Vice President of Investor Relations & Corporate Communications Christian Behrenbruch - Managin...
2024-02-22 17:47:47 ET More on Telix Pharmaceuticals QSAM to be acquired by Telix for $33.1M plus $90M CVR Historical earnings data for Telix Pharmaceuticals Financial information for Telix Pharmaceuticals Read the full article on Seeking Alpha For fu...
MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (U.S. OTC: QSAM) and its lead investigational drug Samarium-153-DOTMP ( 153 Sm-DOTMP). QSAM i...
2024-02-07 16:23:47 ET More on QSAM Biosciences QSAM Biosciences signs term sheet to be acquired by Telix Pharmaceuticals Financial information for QSAM Biosciences Read the full article on Seeking Alpha For further details see: QSAM to be acquired by Tel...
MELBOURNE, Australia, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company’s theranostic programs at the upcoming American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 202...
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, “Telix” or the “Company”) today announces that it is considering an initial public offering (“IPO”) of American Depositary Shares (“ADSs”) repres...
MELBOURNE, Australia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA (US...
2023-10-19 11:20:59 ET More on Telix Pharmaceuticals Historical earnings data for Telix Pharmaceuticals Financial information for Telix Pharmaceuticals For further details see: Telix Pharmaceuticals reports Q3 results
2023-08-23 12:06:48 ET More on Telix Pharmaceuticals Eli Lilly inks licensing deal for cancer therapy with Australian biotech Telix Seeking Alpha Catalyst Watch Earnings data for Telix Pharmaceuticals For further details see: Telix Pharmaceuticals reports...
News, Short Squeeze, Breakout and More Instantly...
Telix Pharmaceuticals Ltd Company Name:
TLPPF Stock Symbol:
OTCMKTS Market:
MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 31 March 2024 (Q1 2024). Summary: Q1 2024 financial performance The Company...
QSAM Biosciences (OTCQB: QSAM) previously announced that it will effectuate a reverse stock split of the issued and outstanding shares of QSAM’s common stock, par value $0.0001 per share, at a ratio in the range of 1:1000 to 1:2000, prior to the closing of the merger between the company a...
FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imaging Collaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as commercial manufacturing and pharmacy distribution partner MELBOURNE, Au...